Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Arcutis Biotherapeutics, Inc. (ARQT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employee Invention Assignment and Confidentiality Agreement by and",
"FOR IMMEDIATE RELEASE Arcutis Appoints L. Todd Edwards"
08/18/2023 8-K Quarterly results
08/14/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
08/08/2023 8-K Quarterly results
Docs: "Arcutis Announces Second Quarter 2023 Financial Results and Provides Business Update"
05/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Arcutis Announces Leadership Transition"
05/09/2023 8-K Quarterly results
Docs: "Arcutis Announces First Quarter 2023 Financial Results and Provides Business Update"
02/28/2023 8-K Quarterly results
12/16/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
09/07/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd."
08/05/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
08/02/2022 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even...
Docs: "FDA APPROVES ARCUTIS’ ZORYVE™ CREAM 0.3% FOR THE TREATMENT OF PLAQUE PSORIASIS IN INDIVIDUALS AGE 12 AND OLDER",
"33.7 41.8 57.7 71.5 13.3 27.8 22.7 13.8 0 10 20 30 40 50 60 70 80 90 100"
06/09/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/22/2022 8-K Quarterly results
Docs: "Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update"
12/23/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Million in Non-Dilutive Debt Financing from SLR Capital"
11/04/2021 8-K Quarterly results
Docs: "Arcutis Announces Third Quarter 2021 Financial Results and Provides Business Update"
10/04/2021 8-K Other Events  Interactive Data
09/27/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
09/03/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/11/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
03/26/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
02/05/2021 8-K Quarterly results
02/01/2021 8-K Quarterly results
01/15/2021 8-K Quarterly results
11/23/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Arcutis Announces Positive Topline Data from Phase 2b Study of ARQ-154 as a Potential Treatment for Scalp and Body Psoriasis"
11/05/2020 8-K Quarterly results
Docs: "Arcutis Announces Third Quarter 2020 Financial Results and Provides Business Update"
11/04/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Arcutis Announces Appointment of Terrie Curran to Board of Directors"
10/06/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy